EDGEWISE THERAPEUTICS INC's ticker is EWTX and the CUSIP is 28036F105. A total of 79 filers reported holding EDGEWISE THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $1,194,000 | -42.4% | 150,000 | -29.8% | 0.22% | -18.6% |
| Q1 2022 | $2,073,000 | -84.0% | 213,744 | -74.9% | 0.27% | -79.9% |
| Q4 2021 | $12,988,000 | +20.8% | 850,000 | +24.7% | 1.34% | +72.9% |
| Q3 2021 | $10,752,000 | -59.1% | 681,812 | -44.6% | 0.78% | -64.9% |
| Q2 2021 | $26,275,000 | -23.5% | 1,231,812 | +16.6% | 2.21% | -34.1% |
| Q1 2021 | $34,346,000 | – | 1,056,812 | – | 3.35% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 1,553,661 | $50,494,000 | 11.75% |
| Novo Holdings A/S | 5,587,207 | $181,584,000 | 7.50% |
| Orbimed Advisors | 13,944,680 | $453,202,000 | 4.24% |
| Logos Global Management LP | 1,056,812 | $34,346,000 | 3.35% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,933,137 | $127,827,000 | 2.69% |
| EcoR1 Capital, LLC | 1,224,175 | $39,786,000 | 1.76% |
| Cormorant Asset Management, LP | 2,340,914 | $74,307,000 | 1.66% |
| Octagon Capital Advisors LP | 125,000 | $4,063,000 | 1.53% |
| RA Capital Management | 2,613,623 | $84,943,000 | 1.28% |
| Soleus Capital Management, L.P. | 100,000 | $3,250,000 | 0.59% |